Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:45 PM

Published 11/03/2009 by Yahoo! Canada


INFORM-1 Results: Robust Antiviral Suppression Achieved with Combination of Nucleoside Analog Polymerase Inhibitor RG7128 and Protease Inhibitor RG722

BOSTON, Nov. 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) and Pharmasset, Inc. (Nasdaq: VRUS) today announced results from all patient cohorts of the INFORM-1 trial, an innovative Phase 1 study of two direct-acting antiviral (DAA) compounds administered without interferon...

Share this 

What others report on the same story

INFORM-1 Results: Robust Antiviral Suppression ...
--- Significant antiviral potency in both naive and treatment-failure patients ---- Promising Safety and Tolerability ---- Phase 2 studies to begin in Q1 2010 -BOSTON, ... - [11/03/2009 - Individual.com]
AASLD: New Drug Boosts HCV Clearance
BOSTON -- Most hepatitis C patients who are initially unresponsive to standard therapy were able to achieve sustained virologic responses when the investigational ... - [11/03/2009 - MedPage Today]
Combination Drugs Are The Future for Hepatitis C
Biotech , Hepatitis C , HIV Steve Worland wrote:Combination therapy has been a central component of treatment for certain viral diseases for more than 15 years. ... - [11/03/2009 - Xconomy]

Quotes

...Gane commented, "The results from this study of the RG7227/RG7128 combination raise hopes that we can deliver an interferon-free regimen for our patients in the future. Current HCV therapy includes up to 12 months of weekly interferon injections which can be associated with significant side effects. In addition, not all patients can take interferon due to intolerance or contraindications. We look forward to the results of additional studies with these potent compounds."
(i) "Combination Therapy with a Nucleoside Polymerase (RG7128) and Protease (RG7227/ITMN-191) Inhibitor Combination in HCV: Safety, Pharmacokinetics, and Virologic Results from INFORM-1" Abstract #193: to be...

Related Stories

First Reported 11/05/2009 - Updated 11/05/2009 - 2 Documents (in Health)
AURORA, OntarioThe double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany 'This is an important milestone for Helix's Topical Interferon Alpha-2b clinical program,' said John Docherty, president and COO of Helix ... [Forbes.com - 11/05/2009]
First Reported 10/27/2009 - Updated 10/27/2009 - 1 Documents (in Conflicts & Crime)
Centers for Disease Control and Prevention - Click to view image in its original context
Centers for Disease Control and Prevention
Health care providers should initiate antiviral treatment as soon as possible for all patients hospitalized with suspected flu, even if flu has not been confirmed by laboratory testing, the Centers for Disease Control and Prevention (CDC) said in an advisory ... [AHA News - 10/27/2009]
Network

Blogs

sort by: Date | Relevance
InterMune, Inc. Q3 2009 Earnings Call Transcript [Biotech Sector and Stocks Analysis from Seeking ... - 11/10/2009]
InterMune, Inc. (ITMN) Q3 2009 Earnings Call November 5, 2009 4:30 pm ETComplete Story » ...
Antiviral cocktail shows promise against resist... [H5N1 - 10/28/2009]
Via Medical News Today.com: Triple-combo Drug Shows Promise Against Antiviral Resistant H1N1. Excerpt:An experimental drug cocktail that includes three prescriptions ...
Is DAS181 the next big antiviral? [H5N1 - 11/06/2009]
Via ElectroIQ.com, a news release about two PLoS ONE articles on NDAS181. Excerpt:One published paper entitled "Novel Pandemic Influenza A(H1N1) Viruses are Potently ...
Ukraine: Pandemic politics [H5N1 - 11/06/2009]
Via the Kyiv Post, a long, discouraging article: Pandemic politics. Excerpt:Early warning signs of the epidemic came between Oct. 12-18 from health workers in Ternopil ...
US: Tamiflu-resistant H1N1 passed person to person [H5N1 - 10/30/2009]
Via Health.com: Tamiflu-Resistant Swine Flu Passed Person-to-Person in U.S. Excerpt:So far, almost all strains of H1N1 have responded to both oseltamivir (Tamiflu) ...
1 2

Audio/Video

sort by: Date | Relevance
Influenza Round Table: Antiviral Drugs [CDC Streaming Health - YouTube - 10/30/2009]
1

  •  
  •  
  •